1-(2-C-cyano-2-deoxy-B-D-arabino-pentafuranosyl)-N4-palmitoylcytosine

1-(2-C-cyano-2-deoxy-B-D-arabino-pentafuranosyl)-N4-palmitoylcytosine
Trade Name Sapacitabine
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2010-06-24 00:00:00
Sponsor Cyclacel Limited;1 James Linday Place, Dundee DD1 5JJ;
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia